UMMS Affiliation

Department of Obstetrics and Gynecology

Date

11-2013

Document Type

Article Preprint

Disciplines

Community Health and Preventive Medicine | Female Urogenital Diseases and Pregnancy Complications | Health Services Administration | Obstetrics and Gynecology | Women's Health

Abstract

Objective: To use the 3 dose Human Papillomavirus (HPV) vaccine administration (given at 0, 1-2 and 6 months) to quantify opportunities to improve efficacy in the delivery of preventive health services.

Methods: This was a retrospective, claims-based analysis using data provided by a single managed care plan. Female patients aged 9-26 who were continuously enrolled between 2009 through 2011 and received ≥ dose of the HPV vaccine during 2010 were analyzed. The proportion of initiators who did and did not completed the vaccine series, the timing and location of doses, and the number of outpatient visits during which the vaccine could have been given to non-completers were determined.

Results: 1,830 patients were analyzed in the 2010 sample. 843 (46%) were continuously enrolled during the three-year observation period. 500 (59%) completed 3 doses. Among completers, the interval range between doses 1 and 2 was 27-619 days (median 96 days). The interval range between doses 2 and 3 was 32-621 days (median 127 days). 261 (52%) completers received dose 2, and 139 (28%) received does 3 over 1 month late. Among the 343 non-completers, 137 (40%), and 206 (60%) completed 1 and 2 doses, respectively. 63% of single-dose recipients and 17% of 2-dose recipients had at least 1 visit within the eligible time period for administration.

Conclusion: Nearly half of HPV vaccine initiators do not complete the vaccine series. Of those who do, a large percentage complete it late. This example quantifies the potential for reminders, registries and outreach to improve on-time dosage and completion.

Comments

Copyright The Authors.

The study reported in this unpublished manuscript was performed in April 2012.

See Additional Files below to view Table 1 and Figures 1 and 2.

Keywords

Human Papilloma Virus, HPV, Vaccine, Quality of Care, Efficacy, Medication Adherence, Guideline Adherence, Missed Opportunities, Health Care Cost, Health Care Access, Health Care Evaluation

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Magee Figure 1 Study Participants.doc (80 kB)
Figure 1. Study participants, females aged 9-27 with at least 1 dose of HPV vaccine in 2010

Magee Figure 2 Interval Visits.doc (57 kB)
Figure 2. Office visits for those not completing vaccine series

Magee Table 1 Missed Opportunities in HPV Vaccination.doc (26 kB)
Table 1. Dosage intervals among those completing a three dose course

 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.